Xylem Inc.
XYL
$122.85
-$0.46-0.37%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.16% | 16.27% | 24.76% | 38.64% | 39.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.16% | 16.27% | 24.76% | 38.64% | 39.51% |
| Cost of Revenue | 6.84% | 15.13% | 25.96% | 41.02% | 42.18% |
| Gross Profit | 10.43% | 18.22% | 22.77% | 34.74% | 35.14% |
| SG&A Expenses | 5.91% | 14.66% | 8.02% | 26.26% | 35.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.22% | 14.44% | 20.32% | 36.01% | 39.43% |
| Operating Income | 22.64% | 30.05% | 63.14% | 59.79% | 40.03% |
| Income Before Tax | 57.16% | 71.18% | 50.16% | 87.89% | 50.64% |
| Income Tax Expenses | 385.71% | 657.69% | -24.59% | -22.34% | -56.25% |
| Earnings from Continuing Operations | 36.35% | 46.14% | 68.70% | 117.33% | 78.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 36.65% | 46.14% | 68.70% | 117.33% | 78.23% |
| EBIT | 22.64% | 30.05% | 63.14% | 59.79% | 40.03% |
| EBITDA | 19.02% | 29.66% | 59.98% | 73.25% | 58.93% |
| EPS Basic | 32.56% | 34.34% | 39.98% | 67.98% | 36.67% |
| Normalized Basic EPS | 18.79% | 18.61% | 37.16% | 25.25% | 9.94% |
| EPS Diluted | 32.20% | 34.37% | 40.27% | 68.57% | 37.15% |
| Normalized Diluted EPS | 19.01% | 18.78% | 37.06% | 25.07% | 9.67% |
| Average Basic Shares Outstanding | 4.53% | 11.78% | 19.86% | 29.31% | 28.73% |
| Average Diluted Shares Outstanding | 4.33% | 11.61% | 19.87% | 29.44% | 29.03% |
| Dividend Per Share | 9.63% | 9.09% | 9.30% | 9.52% | 9.76% |
| Payout Ratio | -0.19% | -0.20% | -0.26% | -0.37% | -0.17% |